Skip to main content
OpenTrials
Completed

NCT Number: NCT05566704

Retrospective Modulus ALIF Study

The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hoag Orthopedics, Orange, California, United States

Loading trial locations.

About this study

Patients considered for this study will have previously undergone surgery for their spinal condition according to the standard of care of the practitioner. All patients at a given site who meet eligibility requirements will be considered for participation in the study. Available progress notes, medical records, patient-reported outcomes, radiographs (plain film and CT scans, if available), and complications will be obtained from the medical records of all enrolled subjects.

The complication profile and overall performance of the Modulus ALIF System will be assessed using the following:

  • Complications attributable to the use of the Modulus ALIF System as noted in surgical summaries, progress notes, and hospital records; and
  • Radiographic outcome (fusion) and description of device status from available plain film radiographs and CT scan(s); and
  • Neurologic status, symptoms, and/or subject self-reported clinical outcomes (e.g., pain and disability), as available

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Availability of progress notes and radiographic information preoperatively and a minimum of 6 months following surgery
  • Male or female patients who are ≥18 years of age at the time of surgery
  • Had undergone a regiment of at least six (6) months of nonoperative care treatment prior to being treated with the Modulus ALIF system, except in patients with progressive neurological deficits, neurogenic claudication causing significant disability, or developed cauda equine syndrome
  • Treated with ALIF procedure with the Modulus ALIF System at:
  • One or two adjacent lumbar and/or lumbosacral levels for degenerative disc disease (DDD), degenerative spondylolisthesis, or spinal stenosis, or
  • Any number of lumbar and/or lumbosacral levels for degenerative scoliosis (defined as >10º coronal curve) or sagittal deformity
  • Supplemental fixation cleared by the applicable regulatory body for use in the thoracolumbar spine unless the procedure meets all of the following criteria:
  • 1-2 levels treated for DDD, and
  • 3 or 4 interfixated screws placed, and
  • Implant lordosis is ≤20°

Exclusion criteria

  • Patient was a prisoner at the time of Modulus ALIF treatment
  • Patient was participating in another clinical study during treatment that would confound study data

Treatment and study plan

Modulus ALIF System

Device

The Modulus ALIF System is designed to address lumbar pathologies utilizing interbody placement through an anterior or anterolateral surgical approach. The Modulus ALIF System is an interfixated interbody system available in various shapes and sizes to suit the individual pathology and anatomical conditions of the patient.

Primary outcomes

  1. Rates of complications attributable to the use of the Modulus ALIF System

    Time frame: 12 months

  2. Proportion of subjects with apparent radiographic fusion at 6 months or greater postoperative

    Time frame: 12 months

Secondary outcomes

  1. Change in neurologic status, symptoms, and/or subject self-reported clinical outcomes (e.g., pain and disability), as available

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

NuVasive

Industry

Registry information

Official study title

An Assessment of the Safety and Performance of the Modulus® ALIF System in Patients Undergoing Anterior Lumbar Interbody Fusion

Important dates

Study start
2022
Primary completion
2022
Study completion
2024
First posted
Oct 4, 2022
Registry last updated
Dec 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.